💡CFS Raises $1B, Eyes IPO in Years
Fusion's Next Big Step: CFS Raising Money and Hiring a Biotech CFO
TL;DR
Commonwealth Fusion Systems raises another billion dollars, bringing total to $5B over seven years. With a new biotech CFO and steady progress on its demo reactor, CFS eyes going public in the next two-three years.
Commonwealth Fusion Systems (CFS) has raised an additional $1 billion, bringing their total funding to $4 billion over seven years. This latest round of investment is significant as it positions the company for a potential IPO within the next two or three years. The appointment of Lorence Kim, CFO from Moderna, signals CFS's readiness to navigate public markets. Kim’s experience with Moderna’s IPO and subsequent growth could be crucial for CFS as they aim to commercialize their fusion technology. Sparc, CFS’s demonstration reactor, is now targeting a launch this year instead of 2025, aiming for scientific breakeven next year.
Key Points
Commonwealth Fusion Systems has raised a total of $5 billion over seven years, including an additional $1 billion recently.
Lorence Kim, former CFO at Moderna, joins CFS as new Chief Financial Officer, bringing expertise in IPOs and public company management.
CFS's Sparc reactor aims to launch this year with scientific breakeven expected next year; initial target was 2025.
The company has selected a site in Chesterfield County, Virginia for its commercial-scale power plant Arc, aiming for operation by the early 2030s.
CFS has sold half of its first power plant's output to Google, securing significant revenue before full commercialization.
Why It Matters
If you're tracking fusion tech investments and IPO trends, CFS’s latest funding round and CFO appointment are key indicators. Moderna's Kim brings invaluable experience in navigating public markets post-IPO, crucial for a company aiming to scale up from demonstration to commercial viability.
Frequently Asked Questions
Why does this matter?
If you're tracking fusion tech investments and IPO trends, CFS’s latest funding round and CFO appointment are key indicators. Moderna's Kim brings invaluable experience in navigating public markets post-IPO, crucial for a company aiming to scale up from demonstration to commercial viability.
What happened?
Commonwealth Fusion Systems raises another billion dollars, bringing total to $5B over seven years. With a new biotech CFO and steady progress on its demo reactor, CFS eyes going public in the next two-three years.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 2,576 builders reading daily.